The α′ subunit of β-conglycinin and the A1-5 subunits of glycinin are not essential for many hypolipidemic actions of dietary soy proteins in rats

European Journal of Nutrition

Volumn 53, Issue 5, 2014, Pages 1195-1207

  Chen, Qixuan ^a,b   Wood, Carla ^a   Gagnon, Christine ^b   Cober, Elroy R ^b   Frégeau Reid, Judith A ^b   Gleddie, Stephen ^b   Xiao, Chao Wu ^a,c  

^a Health Canada and World Health Organization Collaborating Center for Standardization and Evaluation of Biologicals   (Canada)

^b OTTAWA RESEARCH AND DEVELOPMENT CENTRE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Isoflavones; Lipid profiles; Rats; Soy protein; Thyroid hormones

Indexed keywords

AMYLASE; BETA CONGLYCININ ALPHA; CARBOHYDRATE; CASEIN; CREATINE KINASE; FATTY ACID; GLYCININ; GLYCININ A1; GLYCININ A2; GLYCININ A3; GLYCININ A4; GLYCININ A5; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE DERIVATIVE; LACTATE DEHYDROGENASE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SEED STORAGE PROTEIN; SOYBEAN PROTEIN; THYROID HORMONE; UNCLASSIFIED DRUG; BETA-CONGLYCININ PROTEIN, GLYCINE MAX; GLOBULIN; HYPOCHOLESTEROLEMIC AGENT; LIOTHYRONINE; PLANT ANTIGEN; TRIACYLGLYCEROL;

ABDOMINAL FAT; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL ACTIVITY; COMPARATIVE STUDY; DIETARY INTAKE; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; FEMALE; FIBER; FOOD INTAKE; FREE LIOTHYRONINE INDEX; LIPID BLOOD LEVEL; LIVER WEIGHT; MALE; NONHUMAN; NUTRIENT CONCENTRATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN DEPLETION; PROTEIN QUATERNARY STRUCTURE; PROTEIN SUBUNIT; RAT; WEIGHT GAIN; ANIMAL; BLOOD; BODY WEIGHT; CHEMISTRY; DRUG EFFECTS; LIVER; METABOLISM; ORGAN SIZE; PHYSIOLOGY; SOYBEAN; SPRAGUE DAWLEY RAT;

ABDOMINAL FAT; ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTIGENS, PLANT; BODY WEIGHT; CASEINS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; GLOBULINS; ISOFLAVONES; LIVER; MALE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; SEED STORAGE PROTEINS; SOYBEAN PROTEINS; SOYBEANS; TRIGLYCERIDES; TRIIODOTHYRONINE;

EID: 84905984960     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-013-0620-9     Document Type: Article

References (53)

1. Anderson JW, Bush HM (2011) Soy protein effects on serum lipoproteins: a quality assessment and meta-analysis of randomized, controlled studies. J Am Coll Nutr 30:79-91
2. Ascencio C, Torres N, Isoard-Acosta F, Gomez-Perez FJ, Hernandez-Pando R, Tovar AR (2004) Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats. J Nutr 134:522-529 (Pubitemid 38298490)
3. Jenkins DJ, Kendall CW, Jackson CJ, Connelly PW, Parker T, Faulkner D, Vidgen E, Cunnane SC, Leiter LA, Josse RG (2002) Effects of high- and low-isoflavone soy foods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr 76:365-372 (Pubitemid 34804058)
4. Baba T, Ueda A, Kohno M, Fukui K, Miyazaki C, Hirotsuka M, Ishinaga M (2004) Effects of soybean beta-conglycinin on body fat ratio and serum lipid levels in healthy volunteers of female university students. J Nutr Sci Vitaminol (Tokyo) 50:26-31 (Pubitemid 38405205)
5. Rebholz CM, Reynolds K, Wofford MR, Chen J, Kelly TN, Mei H, Whelton PK, He J (2013) Effect of soybean protein on novel cardiovascular disease risk factors: a randomized controlled trial. Eur J Clin Nutr 67:58-63
6. Harland JI, Haffner TA (2008) Systematic review, meta-analysis and regression of randomised controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol. Atherosclerosis 200:13-27
7. Ferreira ES, Silva MA, Demonte A, Neves VA (2011) Soy beta-conglycinin (7S globulin) reduces plasma and liver cholesterol in rats fed hypercholesterolemic diet. J Med Food 14:94-100
8. Moriyama T, Kishimoto K, Nagai K, Urade R, Ogawa T, Utsumi S, Maruyama N, Maebuchi M (2004) Soybean beta-conglycinin diet suppresses serum triglyceride levels in normal and genetically obese mice by induction of beta-oxidation, downregulation of fatty acid synthase, and inhibition of triglyceride absorption. Biosci Biotechnol Biochem 68:352-359 (Pubitemid 39251534)
9. Terpstra AH, Holmes JC, Nicolosi RJ (1991) The hypocholes-terolemic effect of dietary soybean protein versus casein in hamsters fed cholesterol-free or cholesterol-enriched semipurified diets. J Nutr 121:944-947
10. Lovati MR, Manzoni C, Gianazza E, Arnoldi A, Kurowska E, Carroll KK, Sirtori CR (2000) Soy protein peptides regulate cholesterol homeostasis in Hep G2 cells. J Nutr 130:2543-2549
11. Martinez-Villaluenga C, Bringe NA, Berhow MA, de Gonzalez M (2008) Beta-conglycinin embeds active peptides that inhibit lipid accumulation in 3T3-L1 adipocytes in vitro. J Agric Food Chem 56:10533-10543
12. Anthony MS, Clarkson TB, Hughes CL Jr, Morgan TM, Burke GL (1996) Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 126:43-50 (Pubitemid 26030632)
13. Crouse JR III, Morgan T, Terry JG, Ellis J, Vitolins M, Burke GL (1999) A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med 159:2070-2076 (Pubitemid 29453595)
14. Greaves KA, Parks JS, Williams JK, Wagner JD (1999) Intact dietary soy protein, but not adding an isoflavone-rich soy extract to casein, improves plasma lipids in ovariectomized cynomolgus monkeys. J Nutr 129:1585-1592 (Pubitemid 29344609)
15. Fukui K, Tachibana N, Fukuda Y, Takamatsu K, Sugano M (2004) Ethanol washing does not attenuate the hypocholesterolemic potential of soy protein. Nutrition 20:984-990 (Pubitemid 39555499)
16. Lichtenstein AH, Jalbert SM, Adlercreutz H, Goldin BR, Rasmussen H, Schaefer EJ, Ausman LM (2002) Lipoprotein response to diets high in soy or animal protein with and without isoflavones in moderately hypercholesterolemic subjects. Arterioscler Thromb Vasc Biol 22:1852-1858 (Pubitemid 35315772)
17. Takahashi Y, Konishi T (2011) Tofu (soybean curd) lowers serum lipid levels and modulates hepatic gene expression involved in lipogenesis primarily through its protein, not isoflavone, component in rats. J Agric Food Chem 59:8976-8984
18. Coates JB, Medeiros JS, Thanh VH, Nielsen NC (1985) Characterization of the subunits of beta-conglycinin. Arch Biochem Biophys 243:184-194
19. Nielsen NC, Dickinson CD, Cho TJ, Thanh VH, Scallon BJ, Fischer RL, Sims TL, Drews GN, Goldberg RB (1989) Characterization of the glycinin gene family in soybean. Plant Cell 1:313-328
20. Zarkadas CG, Gagnon C, Poysa V, Khanizadeh S, Cober ER, Chang V, Gleddie S (2007) Protein quality and identification of the storage protein subunits of tofu and null soybean genotypes, using amino acid analysis, one- and two-dimensional gel electrophoresis, and tandem mass spectrometry. Food Res Int 40:111-128 (Pubitemid 44738539)
21. Poysa V, Woodrow L, Yu K (2006) Effect of soy protein subunit composition on tofu quality. Food Res Int 39:309-317 (Pubitemid 41773046)
22. Cai T, Chang KC (1999) Processing effect on soybean storage proteins and their relationship with tofu quality. J Agric Food Chem 47:720-727 (Pubitemid 29185251)
23. Kohno M, Hirotsuka M, Kito M, Matsuzawa Y (2006) Decreases in serum triacylglycerol and visceral fat mediated by dietary soybean beta-conglycinin. J Atheroscler Thromb 13:247-255
24. Fassini PG, Noda RW, Ferreira ES, Silva MA, Neves VA, Demonte A (2011) Soybean glycinin improves HDL-C and suppresses the effects of rosuvastatin on hypercholesterolemic rats. Lipids Health Dis 10:165
25. Manzoni C, Duranti M, Eberini I, Scharnag H, Marz W, Castiglioni S, Lovati MR (2003) Subcellular localization of soybean 7S globulin in HepG2 cells and LDL receptor up-regulation by its alpha′ constituent subunit. J Nutr 133:2149-2155 (Pubitemid 36841531)
26. Duranti M, Lovati MR, Dani V, Barbiroli A, Scarafoni A, Castiglioni S, Ponzone C, Morazzoni P (2004) The alpha0 subunit from soybean 7S globulin lowers plasma lipids and upregulates liver beta-VLDL receptors in rats fed a hypercholesterolemic diet. J Nutr 134:1334-1339 (Pubitemid 38720703)
27. Xiao CW, Mei J, Wood CM (2008) Effect of soy proteins and isoflavones on lipid metabolism and involved gene expression. Front Biosci 13:2660-2673 (Pubitemid 351599710)
28. Xiao CW (2008) Health effects of soy protein and isoflavones in humans. J Nutr 138:1244S-1249S
29. AACC International (2013) Approved methods of analysis, 11th edn. Method 20-20.01 determination of isoflavones in soy and selected foods containing soy by extraction, saponification, and liquid chromatography. Method 32-07.01 soluble, insoluble, and total dietary fiber in foods and food products. Method 46-16.01 crude protein-improved Kjeldahl method, copper-titanium dioxide catalyst modification. AACCI: St. Paul, MN, USA. Available at http://methods.aaccnet.org/toc.aspx
30. Reeves PG, Nielsen FH, Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123:1939-1951 (Pubitemid 23342492)
31. Kwon DY, Daily JW III, Kim HJ, Park S (2010) Antidiabetic effects of fermented soybean products on type 2 diabetes. Nutr Res 30:1-13
32. Tsai TY, Chen LY, Pan TM (2012) Effect of probiotic-fermented, genetically modified soy milk on hypercholesterolemia in hamsters. J Microbiol Immunol Infect. doi:10.1016/j.jmii.2012.05.009
33. Lucas EA, Lightfoot SA, Hammond LJ, Devareddy L, Khalil DA, Daggy BP, Soung DY, Arjmandi BH (2003) Soy isoflavones prevent ovariectomy-induced atherosclerotic lesions in Golden Syrian hamster model of postmenopausal hyperlipidemia. Menopause 10:314-321 (Pubitemid 36870503)
34. Chiha M, Njeim M, Chedrawy EG (2012) Diabetes and coronary heart disease: a risk factor for the global epidemic. Int J Hypertens 2012: 697240. doi:10.1155/2012/697240
35. Howard BV, Robbins DC, Sievers ML, Lee ET, Rhoades D, Devereux RB, Cowan LD, Gray RS, Welty TK, Go OT, Howard WJ (2000) LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: the Strong Heart Study. Arterioscler Thromb Vasc Biol 20:830-835 (Pubitemid 30151700)
36. Fassini PG, Ferreira ES, Silva MA, Neves VA, Demonte A (2012) Soybean glycinin (11S) increases HDL-cholesterol in hypercholesterolemic rats. Nutr Food Sci 42:102-110
37. Kostelac D, Rechkemmer G, Briviba K (2003) Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element. J Agric Food Chem 51:7632-7635
38. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM (1991) Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 325:1196-1204
39. Persson L, Henriksson P, Westerlund E, Hovatta O, Angelin B, Rudling M (2012) Endogenous estrogens lower plasma PCSK9 and LDL cholesterol but not Lp(a) or bile acid synthesis in women. Arterioscler Thromb Vasc Biol 32:810-814
40. Windler EE, Kovanen PT, Chao YS, Brown MS, Havel RJ, Goldstein JL (1980) The estradiol-stimulated lipoprotein receptor of rat liver. A binding site that membrane mediates the uptake of rat lipoproteins containing apoproteins B and E. J Biol Chem 255:10464-10471 (Pubitemid 11219979)
41. Gutowska I, Baranowska-Bosiacka I, Nocen I, Piotrowska K, Marchlewicz M, Wiernicki I, Chlubek D, Wiszniewska B (2012) Soy isoflavones administered pre- and postnatally may affect the ERalpha and ERbeta expression and elements' content in bones of mature male rats. Hum Exp Toxicol 31:346-354
42. Oliveira LP, de Jesus RP, Freire TO, Oliveira CP, Castro LA, Lyra LG (2012) Possible molecular mechanisms soy-mediated in preventing and treating nonalcoholic fatty liver disease. Nutr Hosp 27:991-998
43. Kim MH, Kang KS (2012) Isoflavones as a smart curer for nonalcoholic fatty liver disease and pathological adiposity via ChREBP and Wnt signaling. Prev Med 54(Suppl):S57-S63
44. Barth CA, Scholz-Ahrens KE, de Vrese M, Hotze A (1990) Difference of plasma amino acids following casein or soy protein intake: significance for differences of serum lipid concentrations. J Nutr Sci Vitaminol (Tokyo) 36(Suppl 2):S111-S117
45. Scholz-Ahrens KE, Hagemeister H, Unshelm J, Agergaard N, Barth CA (1990) Response of hormones modulating plasma cholesterol to dietary casein or soy protein in minipigs. J Nutr 120:1387-1392
46. Rosalki SB (1998) Low serum creatine kinase activity. Clin Chem 44:905
47. McGrowder DA, Fraser YP, Gordon L, Crawford TV, Rawlins JM (2011) Serum creatine kinase and lactate dehydrogenase activities in patients with thyroid disorders. Niger J Clin Pract 14:454-459
48. Arjmandi BH, Birnbaum R, Goyal NV, Getlinger MJ, Juma S, Alekel L, Hasler CM, Drum ML, Hollis BW, Kukreja SC (1998) Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content. Am J Clin Nutr 68:1364S-1368S (Pubitemid 28550913)
49. Biver E, Chopin F, Coiffier G, Brentano TF, Bouvard B, Garnero P, Cortet B (2012) Bone turnover markers for osteoporotic status assessment? A systematic review of their diagnosis value at baseline in osteoporosis. Jt Bone Spine 79:20-25
50. Castelo-Branco C, Soveral I (2013) Phytoestrogens and bone health at different reproductive stages. Gynecol Endocrinol 29:735-743
51. Chen JR, Zhang J, Lazarenko OP, Cao JJ, Blackburn ML, Badger TM, Ronis MJ (2013) Soy protein isolates prevent loss of bone quantity associated with obesity in rats through regulation of insulin signaling in osteoblasts. FASEB J. doi:10.1096/fj.12-226464
52. Hamden K, Jaouadi B, Carreau S, Aouidet A, Elfeki A (2011) Therapeutic effects of soy isoflavones on alpha-amylase activity, insulin deficiency, liver-kidney function and metabolic disorders in diabetic rats. Nat Prod Res 25:244-255
53. Tarling CA, Woods K, Zhang R, Brastianos HC, Brayer GD, Andersen RJ, Withers SG (2008) The search for novel human pancreatic alpha-amylase inhibitors: high-throughput screening of terrestrial and marine natural product extracts. ChemBioChem 9:433-438